Pascalis Vergidis MD, MSc (@pascalisid) 's Twitter Profile
Pascalis Vergidis MD, MSc

@pascalisid

Associate Professor @MayoClinicINFD | HemOnc ID Chair @MayoTransplant | Microbiology @MayoClinicSOM | Member-At-Large @MSG_ERC | Editor @JournalSpectrum

ID: 1122216245477224451

linkhttps://www.mayoclinic.org/biographies/vergidis-paschalis-m-d/bio-20460355 calendar_today27-04-2019 19:09:37

516 Tweet

1,1K Followers

1,1K Following

Pascalis Vergidis MD, MSc (@pascalisid) 's Twitter Profile Photo

ID Grand Rounds Mayo Clinic Infectious Diseases I discussed the following: - ONE Health - Aspergillus urine antigen - Giant magnetoresistance-enabled PCR - Rezafungin for prevention in bone marrow transplant - Ibrexafungerp (FURI) - Olorofim (Study 32) - Our experience with fosmanogepix

ID Grand Rounds <a href="/MayoClinicINFD/">Mayo Clinic Infectious Diseases</a> 

I discussed the following:
- ONE Health
- Aspergillus urine antigen
- Giant magnetoresistance-enabled PCR
- Rezafungin for prevention in bone marrow transplant
- Ibrexafungerp (FURI)
- Olorofim (Study 32)
- Our experience with fosmanogepix
Jack McHugh (@jamchugh) 's Twitter Profile Photo

My recent work on display ESCMID ESCMID Fungal Infection Study Group (EFISG) looked at rising fluconazole resistance in C. parapsilosis. Our reference lab Mayo Clinic Infectious Diseases has seen a (concerning!) rise in fluconazole resistance from ~5-10% to 20% in the past 3 years. Thanks Pascalis Vergidis MD, MSc for mentorship.

My recent work on display <a href="/ESCMID/">ESCMID</a> <a href="/efisg_escmid/">ESCMID Fungal Infection Study Group (EFISG)</a> looked at rising fluconazole resistance in C. parapsilosis. Our reference lab <a href="/MayoClinicINFD/">Mayo Clinic Infectious Diseases</a> has seen a (concerning!) rise in fluconazole resistance from ~5-10% to 20% in the past 3 years. Thanks <a href="/pascalisID/">Pascalis Vergidis MD, MSc</a> for mentorship.
Harvard University (@harvard) 's Twitter Profile Photo

“No government—regardless of which party is in power—should dictate what private universities can teach, whom they can admit and hire, and which areas of study and inquiry they can pursue.” - President Alan Garber hrvd.me/GarberRespond3…

Jack McHugh (@jamchugh) 's Twitter Profile Photo

New manuscript in Journal of Infectious Diseases - we report a concerning rise in fluconazole resistance in Candida parapsilosis bloodstream isolates at our (referral) lab over the past several years. Consider susceptibility testing prior to transitioning to fluconazole. academic.oup.com/jid/advance-ar…

IDSA (@idsainfo) 's Twitter Profile Photo

"As a pediatrician and an infectious diseases specialist, I want every child to thrive. Vaccines are one of the most powerful, safe and effective tools we have to make that possible," says IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP. IDSA responds to the MAHA report:

"As a pediatrician and an infectious diseases specialist, I want every child to thrive. Vaccines are one of the most powerful, safe and effective tools we have to make that possible," says IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP. 

IDSA responds to the MAHA report:
Pascalis Vergidis MD, MSc (@pascalisid) 's Twitter Profile Photo

In a phase 3 clinical trial, pemivibart provided prophylactic efficacy against COVID-19 in immunocompromised patients and individuals at risk for exposure. Four of 623 participants experienced anaphylactic reactions Clinical Infectious Diseases transplantid.net academic.oup.com/cid/advance-ar…

Pascalis Vergidis MD, MSc (@pascalisid) 's Twitter Profile Photo

High Kaposi sarcoma-associated herpesvirus seroprevalence in donors and recipients with HIV, particularly among MSM. Reassuringly, disease was rare Clinical Infectious Diseases transplantid.net academic.oup.com/cid/advance-ar…

Pascalis Vergidis MD, MSc (@pascalisid) 's Twitter Profile Photo

Synthesis of the available literature on the use of CMV-specific T-cell therapy in adult and pediatric HSCT and SOT recipients. Several patients on concurrent antivirals, which confounded the effectiveness of VSTs Clinical Infectious Diseases transplantid.net academic.oup.com/cid/advance-ar…

Pascalis Vergidis MD, MSc (@pascalisid) 's Twitter Profile Photo

Visited the historic city of Philadelphia to attend the American Board of Internal Medicine (ABIM) New Governance Orientation. Looking forward to serving on the Infectious Disease Approval Committee. Of the profession, for the public American Board of Internal Medicine (ABIM)

Visited the historic city of Philadelphia to attend the American Board of Internal Medicine (ABIM) New Governance Orientation. Looking forward to serving on the Infectious Disease Approval Committee. 

Of the profession, for the public
<a href="/ABIMcert/">American Board of Internal Medicine (ABIM)</a>
Pascalis Vergidis MD, MSc (@pascalisid) 's Twitter Profile Photo

Join us for a panel discussion on “Leveraging Partnerships to Fight Fungal Diseases” ASM Dallas Smith CDC Sean Zhang, Fungal Diagnostics Laboratory Consortium Rob Purdie, MYCology Advocacy, Research & Education Zachary Rubin LA Public Health Me MSGERC

Join us for a panel discussion on “Leveraging Partnerships to Fight Fungal Diseases” <a href="/ASMicrobiology/">ASM</a>

Dallas Smith <a href="/CDCgov/">CDC</a> 
Sean Zhang, Fungal Diagnostics Laboratory Consortium Rob Purdie, MYCology Advocacy, Research &amp; Education
Zachary Rubin <a href="/lapublichealth/">LA Public Health</a> 
Me <a href="/MSG_ERC/">MSGERC</a>
Martin Hoenigl🇺🇦🇦🇹 (@martinhoenigl) 's Twitter Profile Photo

🔥🗞️Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study. Groundbreaking work on a very promising new antifungal. Free access here: authors.elsevier.com/c/1lHca5E-UokK…

Takahiro Matsuo (Taka), MD (@takamatsuo_id) 's Twitter Profile Photo

【Blastemia portrays a poor prognosis in acute leukemia patients with invasive pulmonary aspergillosis】 Excited to share our recent article on the “B-index” in invasive pulmonary aspergillosis! MD Anderson Cancer Center In addition to the D-index, blastemia is an important prognostic

【Blastemia portrays a poor prognosis in acute leukemia patients with invasive pulmonary aspergillosis】

Excited to share our recent article on the “B-index” in invasive pulmonary aspergillosis!
<a href="/MDAndersonNews/">MD Anderson Cancer Center</a>

In addition to the D-index, blastemia is an important prognostic
Mayo Clinic Infectious Diseases (@mayoclinicinfd) 's Twitter Profile Photo

Thursday AM conference at Mayo Clinic Infectious Diseases where our excellent senior fellows Melissa Kerkelis and Jack McHugh present 6 rapid review cases. At our fellowship, Thursday AM conference presents one of the many opportunities for fellows/residents to teach the division. 📖 👓

Thursday AM conference at <a href="/MayoClinicINFD/">Mayo Clinic Infectious Diseases</a> where our excellent senior fellows <a href="/MKerkelis/">Melissa Kerkelis</a> and <a href="/jamchugh/">Jack McHugh</a> present 6 rapid review cases. At our fellowship, Thursday AM conference presents one of the many opportunities for fellows/residents to teach the division. 📖 👓